Rituximab is used in the treatment of non-Hodgkin lymphoma (NHL), blood cancer (chronic lymphocytic leukemia) and rheumatoid arthritis
How it works
Rituximab is a monoclonal antibody that specifically binds to receptors on cancer cells. Thus Rituximab flags the cancer cells for destruction by the body’s immune system.
Common side effects
Headache, Weakness, Edema, Infection, Hair loss, Itching, Chills, Febrile neutropenia, Decreased white blood cell count (neutrophils), Infusion reaction